Oliver Gessner is a seasoned professional in market research and business analytics, currently serving as the Sr. Director of US Market Research and Forecasting for solid tumors at BioNTech SE since May 2025. Previously, Gessner held the position of Executive Director of Business Insights and Analytics in Hematology at Geron Corporation from September 2022 to December 2025. Gessner's extensive experience includes leadership roles at Genmab, Johnson & Johnson Innovative Medicine in various capacities related to oncology and hematology, Bristol Myers Squibb, Somaxon Pharmaceuticals, Novartis, and Bayer. Academic credentials include a Master of Science in Executive Leadership from the University of San Diego and multiple bachelor's degrees in Finance and Banking from Duale Hochschule Baden-Württemberg.
This person is not in the org chart
This person is not in any teams
This person is not in any offices